Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Home Healthcare

PUBLISHER: Grand View Research | PRODUCT CODE: 1571685

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1571685

North America Home Healthcare Market Size, Share & Trends Analysis Report By Component (Equipment, Services), By Indication (Cardiovascular Disorder & Hypertension, Cancer), By Region And Segment Forecasts, 2024 - 2030

PUBLISHED:
PAGES: 80 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 4950
Printable PDF (5-User License)
USD 5950
Printable PDF (Enterprise License)
USD 7950

Add to Cart

Description

Table of Contents

North America Home Healthcare Market Growth & Trends:

The North America home healthcare market size is expected to reach USD 285.05 billion by 2030, registering a CAGR of 7.7% from 2024 to 2030, according to a new report by Grand View Research, Inc. Rising aging human population, high disposable income for healthcare expenditure, and increasing rate of target diseases are some of the key factors driving growth. Predominance of chronic diseases, and increasing diagnosis expenditure is anticipated to boost growth.

Personalized medical assistance is a cost effective measure to control treatment expenditure and acts as a major driver for the industry. According to America's Health rankings, nearly 58 million adults aged 65 and older lived in the U.S. in 2022.

The home healthcare industry is anticipated to be majorly driven by the huge aging population volume which is highly prone to various diseases such as venous stasis ulcers, diabetic ulcers, and pressure ulcers. According to WHO, the global volume of population falls under the age group of 60 years and above has reached 841 million in 2014 and is expected to reach 2 billion by 2050. Therefore, rising global aging-population along with the statistics that approximately 70% of home healthcare patients belong to 65 years and above age group, is anticipated to fuel demand in the near future.

Wound care accounted for 65% of the global market revenue in 2014. Substantial demand for wound closures, wound care dressings, and wound cleanser has resulted in the dominance of the segment over the past few years and this trend is expected to continue over the forecast period. Wound infection is a key safety concern for medical professionals and patients, thus the market is anticipated to fuel the demand as it compelled to reduce the infection rates. Wound care products improve the overall health of patients affected from various disorders such as, diabetic ulcers, pressure ulcers and venous stasis ulcers, therefore creating strong need for these products in the industry.

Rising number of geriatric patients with growing awareness about personal safety and hygiene is further expected to intensify home healthcare service demand in North America. Baxter offers broad solutions to empower healthcare professionals to offer personalized care. It offers products for healthcare professionals for hospital care, primary care, kidney care, surgical care, nutritional care and others.

The services segment accounted for the largest market share of 84.1% in 2023. The segment is further divided into skilled and unskilled homecare. Different services such as nutritional support, nursing care, hospice & palliative, physician primary care, and others are offered by home healthcare services. The accurate diagnosis and medical treatment offered by skilled healthcare is attributing the segment growth. On the other hand, the equipment segment is expected to register the fastest CAGR of 8.6% during the forecast period. The segment is divided into therapeutic, diagnostic, and mobility assist segments.

The U.S. home healthcare market dominated the North America market with a share of 90.0% in 2023 due to advanced healthcare infrastructure. Large base of aging population, growing healthcare infrastructure and high purchasing power are some of the key factors driving growth. Moreover, favorable government initiatives aimed at controlling treatment expenditure by promoting home care services are anticipated to fuel growth. According to the PRB (Population Reference Bureau), at present, approximately 50 million citizens of North America are over 65 years and the number is projected to reach 89 million by 2050.

North America Home Healthcare Market Report Highlights:

  • The services segment accounted for the largest market share of 84.1% in 2023. The segment is further divided into skilled and unskilled homecare.
  • The equipment segment is expected to register the fastest CAGR of 8.6% during the forecast period. The segment is divided into therapeutic, diagnostic, and mobility assist segments.
  • The diabetes & kidney disorders segment accounted for the largest market share in 2023. According to American Diabetes Association, 38.4 million Americans were diagnosed with diabetes in 2021.
  • The mobility disorders segment is projected to grow at the fastest CAGR over the forecast period.
Show more
Product Code: 978-1-68038-607-3

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. North America Home Healthcare Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. North America Home Healthcare Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. North America Home Healthcare Market: Component Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. North America Home Healthcare Market: Component Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Equipment
    • 4.3.1. Equipment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Therapeutic
      • 4.3.2.1. Therapeutic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.2.1.1. Home Respiratory Equipment
          • 4.3.2.1.1.1. Home Respiratory Equipment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.2.1.2. Insulin Delivery Market
          • 4.3.2.1.2.1. Insulin Delivery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.2.1.3. Home IV Pumps
          • 4.3.2.1.3.1. Home IV Pumps Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.2.1.4. Home Dialysis Equipment
          • 4.3.2.1.4.1. Home Dialysis Equipment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.2.1.5. Other Therapeutic Equipment
          • 4.3.2.1.5.1. Other Therapeutic Equipment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Diagnostic
      • 4.3.3.1. Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.3.1.1. Diabetic Care Unit
          • 4.3.3.1.1.1. Diabetic Care Unit Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.3.1.2. BP Monitors
          • 4.3.3.1.2.1. BP Monitors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.3.1.3. Multi Para Diagnostic Monitors
          • 4.3.3.1.3.1. Multi Para Diagnostic Monitors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.3.1.4. Home Pregnancy and Fertility Kits
          • 4.3.3.1.4.1. Home Pregnancy and Fertility Kits Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.3.1.5. Apnea and Sleep Monitors
          • 4.3.3.1.5.1. Apnea and Sleep Monitors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.3.1.6. Holter Monitors
          • 4.3.3.1.6.1. Holter Monitors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.3.1.7. Heart Rate Meters (include pacemakers)
          • 4.3.3.1.7.1. Heart Rate Meters (include pacemakers) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.3.1.8. Others
          • 4.3.3.1.8.1. Other Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.4. Mobility Assist
      • 4.3.4.1. Mobility Assist Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.4.1.1. Wheel Chair
          • 4.3.4.1.1.1. Wheel Chair Assist Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.4.1.2. Home Medical Furniture
          • 4.3.4.1.2.1. Home Medical Furniture Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.4.1.3. Walking Assist Devices
          • 4.3.4.1.3.1. Walking Assist Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Services
    • 4.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Skilled Home Healthcare
      • 4.4.2.1. Skilled Home Healthcare Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.4.2.1.1. Physician Primary Care
          • 4.4.2.1.1.1. Physician Primary Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.4.2.1.2. Nursing Care
          • 4.4.2.1.2.1. Nursing Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.4.2.1.3. Physical/Occupational/Speech Therapy
          • 4.4.2.1.3.1. Physical/Occupational/Speech Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.4.2.1.4. Nutritional Support
          • 4.4.2.1.4.1. Nutritional Support Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.4.2.1.5. Hospice & Palliative
          • 4.4.2.1.5.1. Hospice & Palliative Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.4.2.1.6. Other Skilled Nursing Services
          • 4.4.2.1.6.1. Other Skilled Nursing Se Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Unskilled Home Healthcare
      • 4.4.3.1. Unskilled Home Healthcare Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. North America Home Healthcare Market: Indication Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. North America Home Healthcare Market: Indication Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Cardiovascular Disorder & Hypertension
    • 5.3.1. Cardiovascular Disorder & Hypertension Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Diabetes & Kidney Disorders
    • 5.4.1. Equipment Identification Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Neurological & Mental Disorders
    • 5.5.1. Neurological & Mental Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Respiratory Diseases & COPD
    • 5.6.1. Respiratory Diseases & COPD Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Maternal Disorders
    • 5.7.1. Maternal Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Mobility Disorders
    • 5.8.1. Mobility Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.9. Cancer
    • 5.9.1. Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.10. Wound Care
    • 5.10.1. Wound Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.11. Others
    • 5.11.1. Other Indications Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. North America Home Healthcare Market: Regional Estimates & Trend Analysis

  • 6.1. North America Home Healthcare Market Share, By Region, 2023 & 2030 (USD Million)
  • 6.2. North America
    • 6.2.1. North America North America Home Healthcare Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. North America Home Healthcare Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada North America Home Healthcare Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico North America Home Healthcare Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. B. Braun SE
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/ Strategic Initiatives
    • 7.4.2. Abbott
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/ Strategic Initiatives
    • 7.4.3. Sunrise Medical
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/ Strategic Initiatives
    • 7.4.4. 3M
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/ Strategic Initiatives
    • 7.4.5. Baxter
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/ Strategic Initiatives
    • 7.4.6. Medtronic
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/ Strategic Initiatives
    • 7.4.7. Cardinal Health
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/ Strategic Initiatives
    • 7.4.8. F. Hoffmann-La Roche Ltd
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/ Strategic Initiatives
    • 7.4.9. Amedisys
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/ Strategic Initiatives
    • 7.4.10. ARKRAY, Inc.
      • 7.4.10.1. Participant's Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Recent Developments/ Strategic Initiatives
    • 7.4.11. BD
      • 7.4.11.1. Participant's Overview
      • 7.4.11.2. Financial Performance
      • 7.4.11.3. Product Benchmarking
      • 7.4.11.4. Recent Developments/ Strategic Initiatives
    • 7.4.12. OMRON Healthcare, Inc.
      • 7.4.12.1. Participant's Overview
      • 7.4.12.2. Financial Performance
      • 7.4.12.3. Product Benchmarking
      • 7.4.12.4. Recent Developments/ Strategic Initiatives
    • 7.4.13. GE Healthcare
      • 7.4.13.1. Participant's Overview
      • 7.4.13.2. Financial Performance
      • 7.4.13.3. Product Benchmarking
      • 7.4.13.4. Recent Developments/ Strategic Initiatives
    • 7.4.14. Medline Industries, Inc
      • 7.4.14.1. Participant's Overview
      • 7.4.14.2. Financial Performance
      • 7.4.14.3. Product Benchmarking
      • 7.4.14.4. Recent Developments/ Strategic Initiatives
    • 7.4.15. Koninklijke Philips N.V.
      • 7.4.15.1. Participant's Overview
      • 7.4.15.2. Financial Performance
      • 7.4.15.3. Product Benchmarking
      • 7.4.15.4. Recent Developments/ Strategic Initiatives
    • 7.4.16. Johnson & Johnson Services, Inc.
      • 7.4.16.1. Participant's Overview
      • 7.4.16.2. Financial Performance
      • 7.4.16.3. Product Benchmarking
      • 7.4.16.4. Recent Developments/ Strategic Initiatives
    • 7.4.17. Acelity (3M)
      • 7.4.17.1. Participant's Overview
      • 7.4.17.2. Financial Performance
      • 7.4.17.3. Product Benchmarking
      • 7.4.17.4. Recent Developments/ Strategic Initiatives
    • 7.4.18. Teleflex Incorporated.
      • 7.4.18.1. Participant's Overview
      • 7.4.18.2. Financial Performance
      • 7.4.18.3. Product Benchmarking
      • 7.4.18.4. Recent Developments/ Strategic Initiatives
    • 7.4.19. Fresenius Kabi AG.
      • 7.4.19.1. Participant's Overview
      • 7.4.19.2. Financial Performance
      • 7.4.19.3. Product Benchmarking
      • 7.4.19.4. Recent Developments/ Strategic Initiatives
    • 7.4.20. Bayer AG
      • 7.4.20.1. Participant's Overview
      • 7.4.20.2. Financial Performance
      • 7.4.20.3. Product Benchmarking
      • 7.4.20.4. Recent Developments/ Strategic Initiatives
    • 7.4.21. GF Health Products, Inc.
      • 7.4.21.1. Participant's Overview
      • 7.4.21.2. Financial Performance
      • 7.4.21.3. Product Benchmarking
      • 7.4.21.4. Recent Developments/ Strategic Initiatives
    • 7.4.22. Knight Health Holdings, LLC
      • 7.4.22.1. Participant's Overview
      • 7.4.22.2. Financial Performance
      • 7.4.22.3. Product Benchmarking
      • 7.4.22.4. Recent Developments/ Strategic Initiatives
    • 7.4.23. NHC, National Healthcare Corporation
      • 7.4.23.1. Participant's Overview
      • 7.4.23.2. Financial Performance
      • 7.4.23.3. Product Benchmarking
      • 7.4.23.4. Recent Developments/ Strategic Initiatives
    • 7.4.24. Gentiva
      • 7.4.24.1. Participant's Overview
      • 7.4.24.2. Financial Performance
      • 7.4.24.3. Product Benchmarking
      • 7.4.24.4. Recent Developments/ Strategic Initiatives
    • 7.4.25. Medco Home Healthcare, Inc.
      • 7.4.25.1. Participant's Overview
      • 7.4.25.2. Financial Performance
      • 7.4.25.3. Product Benchmarking
      • 7.4.25.4. Recent Developments/ Strategic Initiatives
    • 7.4.26. Brookdale Senior Living Inc.
      • 7.4.26.1. Participant's Overview
      • 7.4.26.2. Financial Performance
      • 7.4.26.3. Product Benchmarking
      • 7.4.26.4. Recent Developments/ Strategic Initiatives
    • 7.4.27. Sunrise Senior Living
      • 7.4.27.1. Participant's Overview
      • 7.4.27.2. Financial Performance
      • 7.4.27.3. Product Benchmarking
      • 7.4.27.4. Recent Developments/ Strategic Initiatives
    • 7.4.28. Genesis HealthCare
      • 7.4.28.1. Participant's Overview
      • 7.4.28.2. Financial Performance
      • 7.4.28.3. Product Benchmarking
      • 7.4.28.4. Recent Developments/ Strategic Initiatives
    • 7.4.29. EXTENDICARE.
      • 7.4.29.1. Participant's Overview
      • 7.4.29.2. Financial Performance
      • 7.4.29.3. Product Benchmarking
      • 7.4.29.4. Recent Developments/ Strategic Initiatives
    • 7.4.30. Diversicare.
      • 7.4.30.1. Participant's Overview
      • 7.4.30.2. Financial Performance
      • 7.4.30.3. Product Benchmarking
      • 7.4.30.4. Recent Developments/ Strategic Initiatives
    • 7.4.31. Home Instead, Inc.
      • 7.4.31.1. Participant's Overview
      • 7.4.31.2. Financial Performance
      • 7.4.31.3. Product Benchmarking
      • 7.4.31.4. Recent Developments/ Strategic Initiatives
    • 7.4.32. Senior Services of America
      • 7.4.32.1. Participant's Overview
      • 7.4.32.2. Financial Performance
      • 7.4.32.3. Product Benchmarking
      • 7.4.32.4. Recent Developments/ Strategic Initiatives
    • 7.4.33. Atria Senior Living, Inc
      • 7.4.33.1. Participant's Overview
      • 7.4.33.2. Financial Performance
      • 7.4.33.3. Product Benchmarking
      • 7.4.33.4. Recent Developments/ Strategic Initiatives
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!